In MM, activation of both canonical and non-canonical NF-κB pathways are prevalent, which creates inflammatory microenvironment for tumor growth and have been found to be associated with disease progression [11, 53, 57]. This evidence concerns the gene NFKB1 and Miyoshi myopathy.